The Commission has developed information, tools and resources to help support consumers engagement with, and understanding of, safe and high-quality health care.
Found 735 result(s)
The Commission, through QUM Learning (formerly NPS MedicineWise), provides a range of education and training resources on medication safety and quality use of medicines for healthcare professionals and students.
A number of resources have been identified which are relevant to the Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard.
The Commission develops clinical care standards with advice from a multidisciplinary topic working group including clinicians, consumers and researchers.
The standard has been endorsed by a number of key professional associations and health organisations.
The standard contains eight quality statements that describe the health care that people of all ages with cognitive disability or impairment should receive to ensure the safe and appropriate use of psychotropic medicines.
Indicators have been developed to support monitoring of the care recommended in the standard. Clinicians and healthcare services can use the indicators to support local quality improvement activities.
Information for healthcare services to guide practice and monitor improvement using the clinical care standard, and resources to support implementation.
Information about the Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard and supporting resources for clinicians.
The Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard describes the care you should expect to receive to support the safe and appropriate use of psychotropic medicines.
The Commission understands its role as a data custodian of primary healthcare data and is committed to ensuring it is managed in a manner which is consistent with the requirements of relevant state and territory laws and standards.
MedicineInsight is a primary care quality improvement program using data from Australian general practices to support best practice and the post-market surveillance of medicines. It allows general practitioners to reflect on their prescribing patterns and patient care and review their practice results as well as the aggregate of all participating MedicineInsight practices.
This register lists all projects which have been approved to use MedicineInsight data. The project summaries are sourced from the data access form submitted by applicants.
The National Medicines Symposium (NMS) is an annual, cross-disciplinary event bringing together leading organisations, experts, clinicians, consumers and policymakers to discuss and debate key issues around quality use of medicines.